Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Atypical Neurofibroma clinical trials
1 of 3 indexed Atypical Neurofibroma trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Atypical Neurofibroma: 3 US clinical trials tracked, 1 recruiting.
Atypical Neurofibroma is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is David Miller, running 1 of these trials.
Enrollment posture brief
Registry condition atypical-neurofibroma
OPEN 1 | RECR 33% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Atypical Neurofibroma lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Atypical Neurofibroma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Atypical Neurofibroma is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Neurofibromatosis Type 1 Tumor Early Detection Study
David Miller
NCT06515860
Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1
Johns Hopkins University
NCT05677594
Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1
Children's National Research Institute
NCT03820778
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Atypical Neurofibroma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Atypical Neurofibroma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Atypical Neurofibroma page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Atypical Neurofibroma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- David Miller sponsors the most Atypical Neurofibroma trials on record, review their full trial history before evaluating a specific study. See David Miller's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Atypical Neurofibroma condition card totals 3 registered trials; most-linked intervention Whole Body Magnetic Resonance Imaging; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.